Clinical trials
Recruiting Ovarian Neoplasms trials in South Korea
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
45 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2018 | 1 |
| 2020 | 3 |
| 2021 | 3 |
| 2022 | 6 |
| 2023 | 4 |
| 2024 | 7 |
| 2025 | 13 |
| 2026 | 7 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 45 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| AstraZeneca | 5 |
| Daiichi Sankyo | 3 |
| Eli Lilly and Company | 3 |
| Yonsei University | 3 |
| GlaxoSmithKline | 2 |
| K-Group, Beta, Inc., a wholly owned subsidiary of Zentalis Pharmaceuticals, Inc | 2 |
| Merck Sharp & Dohme LLC | 2 |
| National Cancer Center, Korea | 2 |
| Regeneron Pharmaceuticals | 2 |
| Seoul National University Hospital | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Ovarian Neoplasms | 45 |
| Endometrial Neoplasms | 16 |
| Fallopian Tube Neoplasms | 11 |
| Uterine Cervical Neoplasms | 9 |
| Breast Neoplasms | 8 |
| Stomach Neoplasms | 8 |
| Colorectal Neoplasms | 7 |
| Esophageal Neoplasms | 7 |
| Pancreatic Neoplasms | 7 |
| Carcinoma, Non-Small-Cell Lung | 6 |
Trials
Showing 1 to 25 of 45. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.